高强度聚焦超声治疗原发性肝癌的进展  

Advances of High-Intensity Focused Ultrasound Ablation in the Treatment of Primary Liver Cancer

作　　者：郭蕊雨 金成兵[1] 

机构地区：[1]重庆医科大学附属第二医院肿瘤中心,重庆

出　　处：《临床医学进展》2023年第3期3234-3240,共7页Advances in Clinical Medicine

摘　　要：原发性肝癌是最常见的恶性肿瘤之一,发病率高、预后差,其早期临床症状不典型,多数患者确诊时已是不可手术切除的中晚期。对于中晚期肝癌的主要局部治疗手段有肝动脉化疗栓塞、放疗、经皮肝穿刺肿瘤无水酒精注射等。近年来,一种新兴的局部微创治疗方法——高强度聚焦超声在肝癌临床治疗中已逐渐应用。本文就高强度聚焦超声在肝癌综合治疗中的应用进展进行综述,以利于为肝癌患者提供一种可选择的治疗方法。Primary liver cancer is one of the most common malignant tumors with high incidence and poor prognosis. Due to the atypical clinical symptoms in the early stage, most patients are diagnosed at advanced stage. At present, the main therapeutic methods for advanced primary liver cancer in-clude transcatheter arterial chemoembolization (TACE), radiotherapy, percutaneous ethanol intra-tumoral injection, etc. As an emerging mininally invasive technique, high-intensity focused ultra-sound (HIFU) ablation has been extensively used in the treatment of primary liver cancer clinically. We reviewed the progress of HIFU in the treatment of primary liver cancer in this article, in order to provide an alternative treatment for patients with primary liver cancer.

关 键 词：高强度聚焦超声 肝癌 治疗 

分 类 号：R73[医药卫生—肿瘤]